NuWave Investment Management LLC Invests $74,000 in IQVIA Holdings Inc. (NYSE:IQV)

NuWave Investment Management LLC purchased a new stake in IQVIA Holdings Inc. (NYSE:IQVGet Rating) during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 320 shares of the medical research company’s stock, valued at approximately $74,000.

A number of other hedge funds also recently added to or reduced their stakes in IQV. Norges Bank purchased a new position in shares of IQVIA during the fourth quarter worth about $509,423,000. Liontrust Investment Partners LLP purchased a new position in IQVIA during the 3rd quarter worth approximately $220,120,000. AMF Tjanstepension AB acquired a new position in IQVIA during the fourth quarter worth approximately $166,276,000. 1832 Asset Management L.P. lifted its stake in IQVIA by 1,061.8% in the fourth quarter. 1832 Asset Management L.P. now owns 598,612 shares of the medical research company’s stock valued at $169,094,000 after buying an additional 547,089 shares during the last quarter. Finally, Marathon Asset Mgmt Ltd acquired a new stake in shares of IQVIA in the fourth quarter valued at approximately $103,040,000. 87.12% of the stock is currently owned by institutional investors.

A number of brokerages recently weighed in on IQV. Wells Fargo & Company cut shares of IQVIA from an “overweight” rating to an “equal weight” rating and decreased their price target for the stock from $290.00 to $235.00 in a research note on Monday, April 25th. Guggenheim started coverage on IQVIA in a research report on Monday, May 23rd. They issued a “buy” rating and a $244.00 price target on the stock. Piper Sandler raised IQVIA from a “neutral” rating to an “overweight” rating and upped their price objective for the company from $231.00 to $255.00 in a research note on Thursday, April 28th. Barclays dropped their target price on IQVIA from $275.00 to $240.00 in a report on Thursday, April 28th. Finally, Deutsche Bank Aktiengesellschaft increased their price target on IQVIA from $250.00 to $290.00 and gave the stock a “buy” rating in a report on Tuesday, April 12th. Two equities research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the stock. Based on data from, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $277.80.

IQV stock opened at $211.54 on Friday. IQVIA Holdings Inc. has a 52 week low of $194.67 and a 52 week high of $285.61. The company has a current ratio of 0.93, a quick ratio of 0.93 and a debt-to-equity ratio of 2.12. The company has a market cap of $40.04 billion, a P/E ratio of 38.12, a P/E/G ratio of 1.42 and a beta of 1.41. The company’s 50-day moving average price is $212.57 and its 200 day moving average price is $233.50.

IQVIA (NYSE:IQVGet Rating) last released its quarterly earnings results on Wednesday, April 27th. The medical research company reported $2.34 earnings per share for the quarter, topping analysts’ consensus estimates of $2.27 by $0.07. The business had revenue of $3.57 billion for the quarter, compared to analysts’ expectations of $3.54 billion. IQVIA had a return on equity of 28.80% and a net margin of 7.69%. The company’s revenue was up 4.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.05 EPS. On average, equities research analysts expect that IQVIA Holdings Inc. will post 9.48 earnings per share for the current year.

About IQVIA (Get Rating)

IQVIA Holdings Inc provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.

Featured Stories

Want to see what other hedge funds are holding IQV? Visit to get the latest 13F filings and insider trades for IQVIA Holdings Inc. (NYSE:IQVGet Rating).

Institutional Ownership by Quarter for IQVIA (NYSE:IQV)

Receive News & Ratings for IQVIA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IQVIA and related companies with's FREE daily email newsletter.